source
- Kymera Therapeutics to unveil mid‑stage eczema trial data, aiming to challenge DupixentKymera Therapeutics, a Massachusetts‑based biotech, is set to release data from its mid‑stage clinical trial of KT‑621 in eczema before the end of 2026. The trial results are being closely watched…
- U.S. Health Care System's Economics Are Broken, Says Ascendiun CEOPaul Markovich, president and CEO of Ascendiun, argues that the economics of the United States health care system are fundamentally broken. He recounts meeting a healthy, active man in his early 6…